Clinical forum: the responsible use of antimicrobial therapy in the control of clinical mastitis and somatic cell count in dairy herds

The reduction and rationalisation of antibiotics used in mastitis control is an increasingly important area of dairy herd health to consider with clients due to the outcomes of the O'Neill Report and the requirement to reduce overall usage of antibiotic in the livestock sector at a national level. There is much interest around a range of strategies to achieve a reduction in antibiotic use on farm, for example cow-side treatment decisions to not use intramammary therapy and deciding not to treat low cell count cows at drying-off. However, the key driver of a reduction in antibiotic use on farm remains strategies to reduce the rate of new clinical cases and new cell count infections on farm, and therefore avoiding the need for antibiotic treatment of infected cows. This article reviews some recent research literature around some of the areas mentioned, and seeks thoughts from panel members active in mastitis control on farm.

[1]  A. Bradley,et al.  Factors affecting the cost-effectiveness of on-farm culture prior to the treatment of clinical mastitis in dairy cows , 2017, Preventive veterinary medicine.

[2]  S. Godden,et al.  Evaluation of an automated milk leukocyte differential test and the California Mastitis Test for detecting intramammary infection in early- and late-lactation quarters and cows. , 2017, Journal of dairy science.

[3]  C. Holm,et al.  Differential somatic cell count-A novel method for routine mastitis screening in the frame of Dairy Herd Improvement testing programs. , 2017, Journal of dairy science.

[4]  Martin J. Green,et al.  Tool to measure antimicrobial use on farms , 2017, Veterinary Record.

[5]  T. Lam,et al.  Clinical forum: selective dry cow therapy , 2016 .

[6]  M. Green,et al.  An investigation of the efficacy of a polyvalent mastitis vaccine using different vaccination regimens under field conditions in the United Kingdom. , 2015, Journal of dairy science.

[7]  Y. Schukken,et al.  Efficacy of vaccination on Staphylococcus aureus and coagulase-negative staphylococci intramammary infection dynamics in 2 dairy herds. , 2014, Journal of dairy science.

[8]  S. Pyörälä,et al.  Treatment for bovine Escherichia coli mastitis - an evidence-based approach. , 2013, Journal of veterinary pharmacology and therapeutics.

[9]  T. Lam,et al.  Effect of extended cefquinome treatment on clinical persistence or recurrence of environmental clinical mastitis. , 2013, Veterinary journal.

[10]  S. Godden,et al.  The selective treatment of clinical mastitis based on on-farm culture results: I. Effects on antibiotic use, milk withholding time, and short-term clinical and bacteriological outcomes. , 2011, Journal of dairy science.

[11]  H. Simojoki,et al.  Efficacy of enrofloxacin in the treatment of naturally occurring acute clinical Escherichia coli mastitis. , 2010, Journal of dairy science.